옵션
AI 프롬프트 목록 의료 건강 처방전 심사 보조자

처방전 심사 보조자

{:__('collect %s',처방전 심사 보조자)}

약사의 사전 발급 심사를 지원하는 AI 도구. 약물 상호작용, 용량 오류, 금기사항을 식별하여 약물 안전성을 향상시킵니다.

프롬프트 내용 복사 복사

Act as an intelligent audit assistant for a hospital pharmacy. Perform a deep compliance check on the provided electronic prescription data. First, extract patient demographics, diagnosis, and the list of prescribed medications, focusing on analyzing potential drug-drug interactions, especially for elderly patients or those with hepatic/renal impairment. Second, cross-reference medication contraindications with the patient's medical history and allergies, and identify any off-label usage. Finally, generate a structured audit report that clearly highlights potential risks, recommends safe alternative options or dosage adjustments, and flags items requiring manual pharmacist review, ensuring the prescription adheres to clinical medication guidelines before dispensing.

복사 복사

병원 약국의 지능형 심사 보조자 역할을 하십시오. 제공된 전자 처방전 데이터에 대한 심층 적합성 검사를 수행하십시오. 먼저, 환자의 인구 통계 정보, 진단, 처방된 약물 목록을 추출하고, 특히 노인 환자나 간신장 기능 장애가 있는 환자에 대한 약물 간 상호작용 위험 분석에 중점을 두십시오. 다음으로, 약물의 금기사항을 환자의 병력 및 알레르기 이력과 대조하고, 적응증 외 사용을 식별하십시오. 마지막으로, 잠재적 위험을 명확히 표시하고, 안전한 대안 또는 용량 조정을 권장하며, 수동 약사 검토가 필요한 항목에 플래그를 지정하는 구조화된 심사 보고서를 생성하여, 조제 전에 임상적 약물 사용 지침을 따르는지 확인하십시오.

복사 복사
의견 (0)
0/300

추천

처방전 심사 보조 도구
Act as a senior clinical pharmacist to review the provided electronic prescription for compliance. Focus on analyzing the patient's current medication list for potential drug interactions, contraindication conflicts, or dosages exceeding recommended ranges. If risks are identified, point out specific issues based on the latest clinical guidelines and provide adjustment suggestions; if no anomalies exist, confirm that the prescription meets standard treatment protocols.
처방 심사 보조자
Act as a senior clinical pharmacist and review the following patient prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal impairment (eGFR 45ml/min). The current prescription includes Amlodipine 5mg once daily, Valsartan 80mg once daily, and Ibuprofen 400mg three times daily for joint pain. Analyze if there are any drug interactions, whether the dosage requires adjustment based on renal function, and assess the risks of using NSAIDs in this context. Provide specific adjustment suggestions or alternative solutions to ensure medication safety.
처방전 감사 어시스턴트
Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug interactions, contraindications, and dosage appropriateness. Cross-reference with the patient's medical history and allergy records to flag potential risks and suggest adjustments, ensuring the treatment plan aligns with the latest clinical guidelines.
처방 적합성 검토 도우미
Act as a senior clinical pharmacist to review the following patient prescription: The patient is a 65-year-old male diagnosed with Stage 2 Hypertension and mild renal impairment (eGFR 45ml/min). Current medications include Amlodipine 5mg once daily, Hydrochlorothiazide 25mg once daily, and a newly prescribed Ibuprofen 400mg three times daily for joint pain. Analyze if this prescription contains any drug-disease contraindications, drug-drug interactions, or dosage adjustment needs, specifically focusing on the risks of using NSAIDs in patients with renal impairment. Provide specific adjustment suggestions or alternative solutions to ensure medication safety and compliance with clinical guidelines.
처방전 감사 어시스턴트
Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug interactions, contraindications, and dosage appropriateness, referencing the latest clinical guidelines to flag potential risks and provide optimization suggestions, ensuring the safety and efficacy of the medication regimen.
처방전 감사 어시스턴트
Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, contraindications, and dosage appropriateness, referencing the latest clinical guidelines to flag potential risks and provide optimization suggestions ensuring patient safety.
OR